BG101703A - Antiparasitic medicamentous form and method for itsapplication - Google Patents
Antiparasitic medicamentous form and method for itsapplicationInfo
- Publication number
- BG101703A BG101703A BG101703A BG10170397A BG101703A BG 101703 A BG101703 A BG 101703A BG 101703 A BG101703 A BG 101703A BG 10170397 A BG10170397 A BG 10170397A BG 101703 A BG101703 A BG 101703A
- Authority
- BG
- Bulgaria
- Prior art keywords
- itsapplication
- antiparasitic
- closantel
- medicamentous form
- medicamentous
- Prior art date
Links
- 230000002141 anti-parasite Effects 0.000 title 1
- 239000003096 antiparasitic agent Substances 0.000 title 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 abstract 2
- 229950004178 closantel Drugs 0.000 abstract 2
- 208000006968 Helminthiasis Diseases 0.000 abstract 1
- 206010062701 Nematodiasis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940058299 avermectines Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The form is used in the veterinary medicine practice in thecontrol of helminthosis - nematodiasis and trematodosis inruminants. It contains the usual auxiliary substances andcombination of avermectine and closantel and its soluble salts.The ratio between the avermectines and closantel is from 1:12 to1:80. The combination of active ingredients is the above ratioshows synergism.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG101703A BG63072B1 (en) | 1997-06-30 | 1997-06-30 | Antiparasitic medicamentous form and method for its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG101703A BG63072B1 (en) | 1997-06-30 | 1997-06-30 | Antiparasitic medicamentous form and method for its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG101703A true BG101703A (en) | 1997-12-30 |
| BG63072B1 BG63072B1 (en) | 2001-03-30 |
Family
ID=3927149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101703A BG63072B1 (en) | 1997-06-30 | 1997-06-30 | Antiparasitic medicamentous form and method for its application |
Country Status (1)
| Country | Link |
|---|---|
| BG (1) | BG63072B1 (en) |
-
1997
- 1997-06-30 BG BG101703A patent/BG63072B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG63072B1 (en) | 2001-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR1003011B (en) | Novel formulation | |
| PL317105A1 (en) | Compositions containing dna and p53 damaging agents | |
| UA32429C2 (en) | Agent for treatment of patient with enuresis | |
| MX9704030A (en) | 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. | |
| IT8522574A0 (en) | PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR TREATING THE HUMAN BODY WITH IT. | |
| TW347339B (en) | Oral delivery of discrete units | |
| PL311276A1 (en) | Veterinary composition containing a proton pump inhibitor | |
| EP1275396A3 (en) | Use of angiotensin II fragments and analogs thereof in tissue repair | |
| ZA947338B (en) | Use of angiotensin II and analogs thereof in tissue repair | |
| MY125556A (en) | Aqueous formulations of peptide | |
| FI973828L (en) | Compounds and compositions for delivering active ingredients | |
| UA42795C2 (en) | Antiinflammatory means for the external application, containing nimesulid, the method of its obtaining | |
| EP0902789A4 (en) | ||
| AU7916798A (en) | Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat | |
| ATE68686T1 (en) | SYSTEM FOR RELEASING SUBSTANCES IN THE VAGINA. | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| BG102814A (en) | New derivatives of carboxylic acid, their preparation and application | |
| PT1076561E (en) | COMBINATION THERAPY FOR THE TREATMENT OF TUMORS | |
| DK0871467T3 (en) | New formulation for delivery of peptide | |
| BG103262A (en) | Antimycotic gel with high degree of active substance release | |
| ZA935086B (en) | Skin regenerating cosmetic composition | |
| BG101703A (en) | Antiparasitic medicamentous form and method for itsapplication | |
| HU9303324D0 (en) | Substituted 3-amino-quinuclidines | |
| EP0260400A3 (en) | Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)-ethyl]anthranilonitrile | |
| PT83322A (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERTENSION OF BLOOD CONTAINING AN INHIBITOR OF THE ANGIOTENSIN CONVERSATION ENZYME IN SYNERGIC MIX WITH A DIURETIC DRAG AGENT |